Dianthus Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 82.38 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.61B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Details
| Name | Dianthus Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 92 |
| Founded | 2015 |
| Ceo | Marino Garcia |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US2528281080 |
| Cusip | 252828108 |
| Cik | 1690585 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Marino Garcia M.B.A. | President, Chief Executive Officer and Director |
| Ryan Savitz | Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer |
| Dr. Simrat Randhawa M.B.A., M.D. | Executive Vice President and Head of Research & Development |
| Edward G. Carr | Senior Vice President and Chief Accounting Officer |
| Judson Taylor | Senior Vice President and Head of Technical Operations |
| Jennifer Davis Ruff | Vice President and Head of Investor Relations and Corporate Affairs |
| Adam M. Veness Esq. | Senior Vice President, General Counsel and Secretary |
| Kristina Maximenko | Chief People Officer |
| Rashieda Gluck | Head of Clinical Development Operations |
| Scott Nogi M.B.A. | Head of Business Operations |
Contact
| Address | 7 Times Square, 43rd Floor, New York, New York 10036, United States |
| Phone | 929 999 4055 |
| Website | https://dianthustx.com |